经口联合经胸入路内镜甲状腺切除术治疗cT1-2N1bM0甲状腺乳头状癌
本研究回顾性分析10例cT1-2N1bM0甲状腺乳头状癌患者,采用经口联合经胸入路行内镜甲状腺全切及选择性侧颈淋巴结清扫。结果显示该术式可行,中央区及IV区淋巴结经口补充清扫,短期结局满意,4例出现暂时性甲状旁腺功能减退并于1个月内自行恢复。
要点
- 经口联合经胸入路可完成甲状腺全切、中央区清扫及选择性侧颈清扫。
- IV区和VI区淋巴结可经口入路补充清扫,弥补经胸入路困难。
- 短期并发症主要为暂时性甲状旁腺功能减退和颈部麻木,可自行缓解。
核心结论
- 经口联合经胸入路行甲状腺全切、中央区清扫及选择性侧颈清扫是可行的,本队列短期结局满意。
- 该入路可能为cT1-2N1bM0甲状腺乳头状癌患者,尤其是术前发现IV区或VI区转移淋巴结者,提供一种新选择。
研究设计与样本
- 回顾性研究,纳入2020年9月至2021年9月间10例cT1-2N1bM0甲状腺乳头状癌患者。
- 所有患者均接受经口联合经胸入路内镜甲状腺切除术。
主要发现
- 10例均成功完成经胸入路甲状腺全切及选择性侧颈清扫,经口入路完成中央区清扫及IV区淋巴结补充清扫。
- II区阳性/检出淋巴结均数0.6±1.0/9.8±5.0,III-IV区4.6±2.8/23.1±4.7,VI区4.9±3.4/10.3±4.6。
- 4例出现暂时性甲状旁腺功能减退,1个月内自行恢复;5例出现侧颈及耳部麻木,1例出现肢体抬举受限。
- 随访期间无其他并发症或肿瘤复发。
临床怎么用
- 对于cT1-2N1bM0甲状腺乳头状癌,尤其术前发现IV区或VI区转移淋巴结者,可考虑经口联合经胸入路内镜手术。
- 经胸入路完成甲状腺全切及选择性侧颈清扫,经口入路补充中央区及IV区清扫。
局限性
- 回顾性研究,样本量仅10例,随访时间有限。
- 短期结局满意,但长期肿瘤学结局及复发情况需进一步随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent years there have been witnessed considerable advances in endoscopic selective lateral neck dissection (LND). However, dissection of lymph nodes at level IV and level VI via the chest approach is inherently challenging. In this study, we used combined trans-oral and chest approach for endoscopic thyroidectomy in patients with cT1-2N1bM0 papillary thyroid carcinoma (PTC). METHODS: Clinical characteristics and surgical outcomes of ten patients with cT1-2N1bM0 PTC who underwent endoscopic thyroidectomy via combination of trans-oral and chest approach between September 2020 and September 2021 were retrospectively reviewed. RESULTS: All 10 patients successfully underwent total thyroidectomy and selective LND via chest approach, while central neck dissection (CND) and supplementary dissection of lymph nodes at level IV were performed via the trans-oral approach. The mean number of positive/retrieved level II, III-IV, and VI lymph nodes were 0.6 ± 1.0/9.8 ± 5.0, 4.6 ± 2.8/23.1 ± 4.7, and 4.9 ± 3.4/10.3 ± 4.6, respectively. Four patients developed transient hypoparathyroidism which spontaneously resolved within 1 month. Five patients developed numbness of lateral neck and ear and one patient experienced limb lift restriction. No other complications or tumor recurrence occurred during follow-up. CONCLUSION: It is feasible to perform total thyroidectomy, CND, and selective LND via combined trans-oral and chest approach, and satisfactory short-term outcomes were observed in this cohort. This approach may offer one more option for cT1-2N1bM0 PTC patients, especially those in whom metastatic lymph nodes at level IV or level VI are detected by preoperative examination.
引用
- Chen ZX, Cao Y, Yang LM, et al. Endoscopic thyroidectomy via the combined trans-oral and chest approach for cT1-2N1bM0 papillary thyroid carcinoma. Surg Endosc. 2022. PMID: 35732836. doi:10.1007/s00464-022-09376-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。